Corneal haze post photorefractive keratectomy.
Charpentier S, Keilani C, Maréchal M, Friang C, De Faria A, Froussart-Maille F, Delbarre M.
J Fr Ophtalmol. 2021 Nov;44(9):1425-1438. doi: 10.1016/j.jfo.2021.05.006. Epub 2021 Sep 17.
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
Pereira-Souza AL, Ambrósio R Jr, Bandeira F, Salomão MQ, Souza Lima A, Wilson SE.
J Refract Surg. 2022 Nov;38(11):741-746. doi: 10.3928/1081597X-20221018-02. Epub 2022 Nov 1.
Topical Losartan for Treating Corneal Haze After Ultraviolet-A/Riboflavin Collagen Cross-Linking.
Rodgers EG, Al-Mohtaseb Z, Chen AJ.
Cornea. 2024 Sep 1;43(9):1165-1170. doi: 10.1097/ICO.0000000000003527. Epub 2024 Mar 22.
Corneal Haze Following Refractive Surgery: A Review of Pathophysiology, Incidence, Prevention, and Treatment.
Margo JA, Munir WM.
Int Ophthalmol Clin. 2016 Spring;56(2):111-25. doi: 10.1097/IIO.0000000000000112.
Mediators of Corneal Haze Following Implantation of Presbyopic Corneal Inlays.
Fenner BJ, Liu YC, Koh SK, Gao Y, Deng L, Beuerman RW, Zhou L, Theng JTS, Mehta JS.
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):868-876. doi: 10.1167/iovs.18-25761.
Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis.
Chang YM, Liang CM, Weng TH, Chien KH, Lee CH.
Acta Ophthalmol. 2021 Sep;99(6):652-662. doi: 10.1111/aos.14704. Epub 2020 Dec 16.
Corneal Haze After Transepithelial Collagen Cross-linking for Keratoconus: A Scheimpflug Densitometry Analysis.
J Lai M, Greenstein SA, Gelles JD, Hersh PS.
Cornea. 2020 Sep;39(9):1117-1121. doi: 10.1097/ICO.0000000000002334.
Corneal Opacity: Cell Biological Determinants of the Transition From Transparency to Transient Haze to Scarring Fibrosis, and Resolution, After Injury.
Wilson SE, Sampaio LP, Shiju TM, Hilgert GSL, de Oliveira RC.
Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):22. doi: 10.1167/iovs.63.1.22.
Topical losartan ophthalmic drops - a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications.
Abdelghaffar M, Güell JL, Moura-Coelho N.
Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):925-934. doi: 10.1007/s00417-024-06710-8. Epub 2024 Dec 12.
Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK.
Carlos de Oliveira R, Wilson SE.
Exp Eye Res. 2020 Nov;200:108218. doi: 10.1016/j.exer.2020.108218. Epub 2020 Sep 6.
